文献速递新发突发、热带与寄生虫病

超越中和抗体水平:NIH单价登革热疫苗诱导抗体的表位特异性

Beyond Neutralizing Antibody Levels: The Epitope Specificity of Antibodies Induced by National Institutes of Health Monovalent Dengue Virus Vaccines.
PubMed 文献 · J Infect Dis · 2019-01-01

该研究通过去pletions和重组嵌合表位移植登革病毒,评估了接种NIH单价登革疫苗志愿者体内疫苗诱导中和抗体的分子特异性及靶向表位。结果显示单价接种后受试者产生高水平中和抗体,主要靶向各血清型独特表位;DENV1、2、4单价疫苗诱导的型特异性中和抗体针对已知强中和抗体识别的四级结构包膜表位。结论提示抗体分子特异性可为确定保护性免疫关联提供新策略。

要点

  • NIH单价登革疫苗诱导的中和抗体主要靶向各血清型独特表位
  • DENV1、2、4单价疫苗诱导向四级结构包膜表位的中和抗体
  • 抗体表位特异性可补充中和抗体水平用于保护关联评估

核心结论

  • 疫苗诱导中和抗体的分子特异性有助于建立超越抗体水平的保护性免疫关联。

研究设计与样本

  • 使用去pletions和重组嵌合表位移植登革病毒,评估接种NIH单价登革疫苗志愿者的中和抗体分子特异性并绘制靶向表位。

主要发现

  • 单价接种后受试者产生高水平中和抗体,主要靶向各血清型独特表位。
  • DENV1、2、4单价疫苗诱导的型特异性中和抗体针对四级结构包膜表位。

临床怎么用

  • 评估登革疫苗免疫原性时,除中和抗体水平外应关注抗体表位特异性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Dengue virus is an emerging mosquito-borne flavivirus responsible for considerable morbidity and mortality worldwide. The Division of Intramural Research, National Institute of Allergy and Infectious Diseases of the US National Institutes of Health (NIH) has developed live attenuated vaccines to each of the 4 serotypes of dengue virus (DENV1-4). While overall levels of DENV neutralizing antibodies (nAbs) in humans have been correlated with protection, these correlations vary depending on DENV serotype, prevaccination immunostatus, age, and study site. By combining both the level and molecular specificity of nAbs to each serotype, it may be possible to develop more robust correlates that predict long-term outcome. METHODS: Using depletions and recombinant chimeric epitope transplant DENVs, we evaluate the molecular specificity and mapped specific epitopes and antigenic regions targeted by vaccine-induced nAbs in volunteers who received the NIH monovalent vaccines against each DENV serotype. RESULTS: After monovalent vaccination, subjects developed high levels of nAbs that mainly targeted epitopes that are unique (type-specific) to each DENV serotype. The DENV1, 2, and 4 monovalent vaccines induced type-specific nAbs directed to quaternary structure envelope epitopes known to be targets of strongly neutralizing antibodies induced by wild-type DENV infections. CONCLUSIONS: Our results reported here on the molecular specificity of NIH vaccine-induced antibodies enable new strategies, beyond the absolute levels of nAbs, for determining correlates and mechanisms of protective immunity.

来源:J Infect Dis,查看原文。版权归原作者所有。

引用

  1. Swanstrom JA, Nivarthi UK, Patel B, et al. Beyond Neutralizing Antibody Levels: The Epitope Specificity of Antibodies Induced by National Institutes of Health Monovalent Dengue Virus Vaccines. J Infect Dis. 2019. PMID: 30895307. doi:10.1093/infdis/jiz109

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。